Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Midface

Maio, Maurício de; Swift, Arthur; Signorini, M.; Fagien, Steven

doi:10.1097/prs.0000000000003716

Cited by 125 publications

(88 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Undesirable effects in patients treated with hyaluronic acid fillers include immediate reactions, such as oedema, and erythema, paraesthesia, pain, bruising and haematoma . Placement‐related undesirable effects include lumps and the Tyndall effect at the injection site.…”

Section: Introductionmentioning

confidence: 99%

Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes

Goodman

Liew²,

Callan

et al. 2020

Aust J Dermatology

View full text Add to dashboard Cite

Facial aesthetic treatment with injectable neuromodulators and hyaluronic acid fillers is well established, with favourable safety profiles and consistent outcomes. As with any medical treatment, adverse events and complications may occur. Adverse events associated with these products are typically transient and mild to moderate in severity. Serious adverse events, such as infection and intravascular occlusion, are rare. Proper patient selection, consent and counselling, preparation and impeccable injection technique are important risk reduction strategies. Both clinicians and patients must be alert to the signs and symptoms of complications so that appropriate treatment can be started promptly. In this article, the authors review the current literature and provide their consensus recommendations for minimising adverse outcomes when treating patients with botulinum toxin or hyaluronic acid fillers.

show abstract

Section: Introductionmentioning

confidence: 99%

Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes

Goodman

Liew²,

Callan

et al. 2020

Aust J Dermatology

View full text Add to dashboard Cite

show abstract

“…Current dermal filler injection techniques highlight the third dimension in rejuvenation—volume. These volumetric approaches target compartment‐specific 3 or esthetic subunits‐specific 23 midfacial volume loss. Although this paradigm shift is a significant milestone in facial rejuvenation, volume augmentation alone does not address the inferior descent of midfacial fat compartments and the inferior volume shift within the compartments.…”

Section: Discussionmentioning

confidence: 99%

Vectorial facial sculpting: A novel sub‐SMAS filler injection technique to reverse the impact of the attenuated retaining ligaments

Cohen

Artzi

Mehrabi

et al. 2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background Age‐related attenuation of the orbital, zygomatic, and masseteric ligaments contribute to temporal brow ptosis, deepening nasolabial fold, and jowl, respectively. Aims To present and assess the vectorial facial sculpting (VFS) technique, a novel nonsurgical panfacial rejuvenation method which focuses on reversal of the impact of attenuated ligaments on the aging face. Methods This case series included women who underwent vectorial facial sculpting at a private clinic from June 2018 to January 2019. Sagging tissues in the lateral brow, nasolabial fold, and jowl were repositioned in a directed manner with vectors whose cross‐product counteracted the vector of the respective causative attenuated ligament. Filler material was deposited into the supraperiosteal/sub‐SMAS plane in right angle vectors at the lateral supra‐orbital rim for brow ptosis, pre‐auricular and malar region for nasolabial fold and across the jawline region for jowl. Standardized photographs were taken before and at 3 months following treatment. Outcome was assessed by both the patients and an independent investigator using a validated Global Aesthetic Improvement Scale. Adverse outcomes were documented. Results Forty‐five patients of mean age 59.8 ± 3.9 years were included. Mean Global Aesthetic Improvement Scale scores for patients and an independent investigator alike at 3 months following treatment indicated “very much improved” (1.44 ± 0.66 and 1.56 ± 0.78, respectively). The procedure was well tolerated with no adverse events. Conclusion Vectorial facial sculpting is a comprehensive anatomical approach for nonsurgical directional tissue mobilization. Based on physical and mathematical rules to reverse the respective causative attenuated ligament, the technique effectively and safely restores youthful facial contours.

show abstract

“…Interestingly our patients did not experience any pain or discomfort during and after the HA dermal filler procedure. In the literature, some manoeuvres have been reported to reduce the risk of vascular damage, such as aspiration during infiltration 11 , low pressure injection, continuously moving the needle or cannula while injecting, injection of small quantities (maximum 0.1 mL of filler per pass) 12 , observing skin changes during the immediate post-injection phase, and excellent knowledge of anatomy 13– 15 . Typically in areas with terminal vascular circulation, the cutaneous vessels suffering may be more likely; in our cases it is one of the most vascularized areas of the face, the nasolabial folds 15 .…”

Section: Discussionmentioning

confidence: 99%

Early hyaluronidase use in preventing skin necrosis after treatment with dermal fillers: Report of two cases

et al. 2019

View full text Add to dashboard Cite

Injection of dermal fillers, like hyaluronic acid (HA), is a safe procedure, with few and transient side effects such as erythema, bruising and swelling etc. The aim of this report is to provide our protocol for the early treatment of necrotic complications after facial treatment with dermal fillers. We present two cases of skin suffering of the face after dermal infiltration of HA, treated successfully with our early protocol. Our protocol includes the early infiltration of hyaluronidase in the treated areas. We start with infiltration of hyaluronidase distributed over the area to be treated through micro-injections with dosage 40 IU per cm2. Our protocol includes the use of systemic corticosteroids for 4 days, anti-aggregation therapy, oral antibiotic, topical cream with nitric oxide and compresses with gauze and warm water. In the skin complications after dermal filler treatment, marked pain and characteristic reticulated erythema in the skin distribution of the affected vessels is often developed. Due to the implementation of our protocol in these patients, we managed to avoid an irreversible necrotic complication of the face in both cases. In this report, our protocol was compared with results published in the literature and allowed us to avoid complications such as skin necrosis with permanent damage.

show abstract

Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Midface

Cited by 125 publications

References 9 publications

Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes

Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes

Vectorial facial sculpting: A novel sub‐SMAS filler injection technique to reverse the impact of the attenuated retaining ligaments

Early hyaluronidase use in preventing skin necrosis after treatment with dermal fillers: Report of two cases

Contact Info

Product

Resources

About